Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal study

OBJECTIVE: Long-term extension (LTE) studies of belimumab in SLE do not include a comparator arm, preventing comparisons between belimumab plus standard therapy and standard therapy alone for organ damage accrual. Propensity score matching can be used to match belimumab-treated patients from LTE stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Urowitz, Murray B, Ohsfeldt, Robert L, Wielage, Ronald C, Dever, John J, Zakerifar, Mehdi, Asukai, Yumi, Ramachandran, Sulabha, Joshi, Ashish V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555104/
https://www.ncbi.nlm.nih.gov/pubmed/33051264
http://dx.doi.org/10.1136/lupus-2020-000412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555104/
https://www.ncbi.nlm.nih.gov/pubmed/33051264
http://dx.doi.org/10.1136/lupus-2020-000412

Ejemplares similares